Olaf Sommerburg

11PUBLICATIONS
33CO-AUTHORS
Fluid-structure interaction and aeroacousticsWastewater treatment processesNeonatologyHaematological tumoursInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 18, 2025
Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.

Olga Halle, Simon Y Graeber, Julia Kontsendorn

|Oct 25, 2024
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic Fibrosis.

Susanne Naehrig, Christina Shad, Magdalena Breuling

|Jun 20, 2024
Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.

Mirjam Stahl, Martha Dohna, Simon Y Graeber

|Jan 22, 2024
Influence of Season, Storage Temperature and Time of Sample Collection in Pancreatitis-Associated Protein-Based Algorithms for Newborn Screening for Cystic Fibrosis.

Pia Maier, Sumathy Jeyaweerasinkam, Janina Eberhard

|Dec 22, 2023
Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening-Towards a Consistent Definition and Data Acquisition.

Anne Munck, Kevin W Southern, Jared Murphy

|Apr 03, 2023
Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis.

Patricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg

Pageof 2

Frequent Collaborators

6 joint publications

Marcus A Mall

4 joint publications

Mark O Wielpütz

4 joint publications

Simon Y Graeber

4 joint publications

Mirjam Stahl